Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artivion (AORT) Cash & Equivalents (2016 - 2025)

Artivion (AORT) has disclosed Cash & Equivalents for 16 consecutive years, with $64.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 21.41% year-over-year to $64.9 million, compared with a TTM value of $64.9 million through Dec 2025, up 21.41%, and an annual FY2025 reading of $64.9 million, up 21.41% over the prior year.
  • Cash & Equivalents was $64.9 million for Q4 2025 at Artivion, down from $73.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $73.4 million in Q3 2025 and bottomed at $10.1 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $50.3 million, with a median of $53.5 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents plummeted 84.44% in 2022, then soared 432.1% in 2023.
  • Year by year, Cash & Equivalents stood at $55.0 million in 2021, then decreased by 28.47% to $39.4 million in 2022, then surged by 49.78% to $58.9 million in 2023, then decreased by 9.29% to $53.5 million in 2024, then increased by 21.41% to $64.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for AORT at $64.9 million in Q4 2025, $73.4 million in Q3 2025, and $53.5 million in Q2 2025.